Showing results (261-270 of 280) with videos related to
Sort By:
Pageof 28
Haematologica|October 12, 2019
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocolsGunnar Cario, Veronica Leoni, Valentino Conter, et al.Leukemia|June 22, 2018
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trialMeinolf Suttorp, Philipp Schulze, Ingmar Glauche, et al.Blood|March 22, 2024
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosisLennart Lenk, Irène Baccelli, Anna Laqua, et al.Oncotarget|July 25, 2016
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemiaChiara Palmi, Angela M Savino, Daniela Silvestri, et al.European Journal of Cancer (Oxford, England : 1990)|February 18, 2019
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in childrenAndrew D J Pearson, Nicole Scobie, Koenraad Norga, et al.Blood Advances|August 28, 2020
The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALLBeat Bornhauser, Gunnar Cario, Anna Rinaldi, et al.Haematologica|April 5, 2011
Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemiaAmy L Sherborne, Kari Hemminki, Rajiv Kumar, et al.Nature Genetics|May 11, 2010
Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia riskAmy L Sherborne, Fay J Hosking, Rashmi B Prasad, et al.Blood|January 27, 2017
Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemiaViktoras Frismantas, Maria Pamela Dobay, Anna Rinaldi, et al.Blood|November 14, 2013
Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study groupTrudy D Buitenkamp, Shai Izraeli, Martin Zimmermann, et al.Pageof 28